Access to Medicines Making Innovation work for the poor Corinna Heineke Diversity in Innovation European Patent Conference, Brussels, 15/16 May 2007.

Slides:

Advertisements

Similar presentations

Intellectual property rights and procurement = international developments & national experiences = Bi-regional Workshop on procurement and supply management.

Advertisements

Consultative expert working group - proposals Barcelona

Summary of 3 rd CEWG meeting by Chair and Vice-Chair Open Session CEWG on R&D Financing and Coordination November 18, 2011.

A TRADE FRAMEWORK FOR INTELLECTUAL PROPERTY RIGHTS, EQUITY PRICING AND MARKET SEGMENTATION Juan Rovira The World Bank Health, Nutrition and Population.

The Intellectual Property Rights Regime in India & US: The Evolving Landscape February 15, 2014, The Hyatt Regency Hotel, New Delhi D. CALAB GABRIEL.

2 nd WIPO Inter-Regional Meeting on South- South Cooperation on Patents, Trademarks, Geographical Indications, Industrial Designs and Enforcement Cairo.

Jean O. Lanjouw February, 2003 The Global Patent System and the Availability of Pharmaceuticals in Poor Countries.

J.P. Singh Georgetown University Communication, Culture, & Technology Program TRIPS: Negotiating Intellectual Property in the World Trading System J.

The World Public Health at a Crossroad Guillermo Foladori CSPO Columbia University 2003 Meeting “The Uneven Evolution of Medical Know-how” Burden Room,

National symposium on Competition law: Evolution and Transition, 2012 Competition Policy for IP Issues Pradeep S Mehta Secretary General, CUTS International.

The role of commercial enterprises in health Dr. Petra Laux, GSK Brussels September 2001.

“Using Competition Law to Promote Access to Health Technologies” Access to Innovation: Making Generic Versions of Newer ARVs Affordable 24 July 2014 Melbourne,

A revised framework for global medicine access Sanjay Basu Reblaw X.

Game Changers Radicalization of ART tools and delivery New ways to manage IP: aggressive use of TRIPS flex and effective patent pool Financial transaction.

Access to essential medicines of the future Bernard Pécoul Director, Campaign for Access to Essential Medicines Médecins Sans Frontières.

Intellectual Property Rights, Services and Trade Facilitation CARSTEN FINK African/LDCs Ambassadors Seminar on Post-Hong Kong Assessment of the Doha Round,

More on Generic Drugs Global Classrooms 2013 Rachel Hunkler.

IP News 指導老師：李柏靜學生：黃馨葦 M /3/26.  Citing the high cost of one of the pharmaceutical industry's expensive new cancer drugs, India's patent.

1 ICC and AIPLA Paris, September 13, 2002 Felix Addor Chief Legal Officer and Deputy Director General Swiss Federal Institute of Intellectual Property.

A very short introduction to patents & access to medicines.

Essential Medicines Programmes Sudan now Essential Medicines Programmes Sudan now.

Hong Kong Agreement on IPR and Access to Medicines: Public Health & Human Rights Considerations J. Craig Phillips LLM, MSN, ARNP, BC, ACRN Florida International.

Washington D.C., USA, July 2012www.aids2012.org Intellectual Property-related challenges: A Latin America Perspective GraciaVioleta Ross

1 Who will innovate to meet the health needs of low income populations in developing countries? Joanna Chataway ESRC INNOGEN Centre Dinar Kale ESRC INNOGEN.

PATENTS AND HEALTH. A CASE STUDY OF THE UGANDAN CONTEXT. (PHA3 JULY 7 TH 2012 –CAPE TOWN, SOUTH AFRICA) MS. MARIAM AKIROR LLB (HONS) / DIP. SW / CPC. PROG.

Action against AIDS, Germany: Dr. Christiane Fischer MD PHD (presenter )(BUKO Pharma-Kampagne), Astrid Berner Rodoreda (Bread for the World) Igor Oliynyk.

1 Patents and Public Health Dr. Eric Noehrenberg Director International Trade and Market Policy, IFPMA WIPO Open Forum on the draft SPLT, Geneva, 3 March.

UK Policy considerations on increasing access to medicines for the poor in developing countries. DEPARTMENT FOR INTERNATIONAL DEVELOPMENT.

Pricing and the Pharmaceutical Industry What’s Realistic? What’s Smart? What’s Right?

WHO Perspective on Medicine Patents and FTAs Asian Regional Workshop on FTAs August, 2005, Kuala Lumpur, Malaysia Dr Zafar Mirza Regional Adviser,

1 CUTS International Capacity Building Training Programme on Advance IPR, WTO-Related Issues and Patent Writing April 28-May 02, 2008, Jaipur Session 10.

Data Exclusivity and Access to Medicines – Empirical Evidence Hearing European Parliament: EU-India Free Trade Agreement: What Future for Patients in Developing.

Global Patent Debate K.Ravi Srinivas May 12-13, 2011.

Incentives for Innovation (Push and Pull) Andrew Alexandra Director Australian Research Council Special Research Centre for Applied Philosophy and Public.

Sustainable Approaches to Opening Access to Medical Inventions James Love Wizards of OS Berlin 15 Sept 06.

© IFPMA 2009WIPO Open-ended Forum on Proposed Development Agenda Projects - 13/10/2009 IFPMA views on the strategic use of information for sustainable.

Intellectual Property Rights and Pharmaceuticals (Case study- Novartis’s claim in India) Background note prepared for PHM Vic Internet Workshop.

Intellectual Property Rights and Pharmaceuticals (Following Up the ‘Novartis case’ ) Background note prepared for PHM Vic Internet Workshop.

Pricing and the Pharmaceutical Industry What’s Realistic? What’s Smart? What’s Right?

Dr. Simon Guentner Senior Policy Officer Social Affairs EUROCITIES The role of cities in promoting Active Inclusion.

Campana Salud para el Desarrollo Barcelona – Diciembre 2008 Judit Rius Sanjuan Knowledge Ecology International (KEI) Perspectivas futuras en la OMS.

TRIPS TRIPS is the Agreement on Trade Related Aspects of Intellectual Property Rights Framed within the WTO, by “consensus” Regulates intellectual property.

PATENT POOL & its CONCERNS PATENT POOL & its CONCERNS Manmohan A Amonkar 20 July 2010.

Donors, prize funds and patent pools. KEI & UNU- MERIT Maastricht Workshop on Medical Innovation Prizes January 28th-29th 2008 Michelle Childs, Head of.

Ron marchant CB FRSA Access to Knowledge and Technologies, IP and Strategies for Green Technologies WIPO ASIA-PACIFIC CONFERENCE ON NATIONAL IP STRATEGIES.

A presentation by Moses Nkomo Intellectual Property Attorney and Consultant National Workshop on TRIPS and access to medicines in Zimbabwe Holiday Inn,

Preliminary classification of proposals by the CEWG Proposals for innovative financing: Discussing the work to-date of WHO’S Consultative Expert Working.

The Intellectual Property Provisions of Recent US FTAs CARSTEN FINK Video Conference for Andean Countries on Intellectual Property Rights, May 4, 2005.

Competition and Intellectual Property Protection in the Pharmaceutical Sector Alexey Ivanov Director, HSE-Skolkovo Institute for Law and Development Director,

Access to medicines challenges in Europe: What is wrong and the way forward Presented by: Rohit Malpani Director of Policy & Analysis, Access Campaign.

NAFTA, CAFTA and Access to Medicines and Food Security in Latin America International Aids Conference Session “Globalization and FTAs: their impact, access.

Patents & Public Health

How Advocacy can Influence Pricing & Policy

Intellectual Property Protection and Access to Medicines

Making medicines, diagnostics and other commodities more affordable

Q: When did the Age of Imperialism begin

PATENTS, TRIPS, FLEXIBILITIES & ACCESS TO MEDICINES

Carnegie Institution of Washington

Capitalisation of R&D in national accounts

Policy Options for Low and Middle Income Countries (LMIC)

Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies Introduction and Overview May 30 to June 4, 2005 Abuja, Nigeria.

The role of cities in promoting Active Inclusion

Obligation to contribute to R&D costs Use of pharmaceutical inventions without authorization of patent owners James Love. CPTech 16 April 2004 Twelfth.

FURNITURE NEW EUROPEAN SKILLS 2020

International Trade and Economic Development Division

Summary of 3rd CEWG meeting by Chair and Vice-Chair

Patent enforcement in Poland – Hot topics

The problem of high prices

Intellectual Property Rights in Medicines Procurement

Presentation transcript:

Access to Medicines Making Innovation work for the poor Corinna Heineke Diversity in Innovation European Patent Conference, Brussels, 15/16 May 2007

Projected new cases of cancer by 2020 Source: WHO: World Cancer Report, 2006.

TRIPS-Flexibilities Compulsory Licensing Parallel Importing Early-working (Bolar) provision Definition of novelty (e.g. India)

Novartis in India Cancer drug Glivec Novartis challenges both Patent ruling and Section 3(d) of. Potential effects on other developing countries

Solutions for access to medicines from the corporate sector Voluntary Licensing Donation Programmes Tiered pricing – Differentiation between developed, developing and least- developed countries

Further solutions Medical Innovation Prize Funds Patent pooling Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (WHO) Drugs for Neglected Diseases Initiative (Advance Market Commitments)

Thank you!